EducationPhD University of Oslo (Norway), 1996 (Epidemiology)
MS University of Zagreb (Yugoslavia), 1991 (Biostatistics)
MD University of Zagreb (Yugoslavia), 1987 (Internal Medicine)
Contact Infoemail: firstname.lastname@example.org
4333 Brooklyn Ave NE, Rm 14-315
Seattle, WA 98195-9455
campus box: 359455
Dr. Kopjar is an internationally recognized scholar and expert in biostatistics and clinical epidemiology. He serves as an author/co-author on over 500 published original articles, reviews, technical reports and abstracts. His research interests include: spinal cord injury and diseases, neurosurgery, orthopaedics, preventive medicine and healthcare reform. Dr. Kopjar has been actively participating in the design, management and analysis of clinical trials and medical research for more than 30 years. He is a frequent contributor to such peer-reviewed publications as the Journal of Neurosurgery, the American Journal of Public Health, Spine and the Journal of Bone and Joint Surgery. In the 1990’s he served as the research director for the Norwegian Foundation for Health Services Research and department head of the Section for Preventive Medicine at the Norwegian National Institute of Public Health. As a consultant, he works closely with the leading global pharmaceutical, medical device and venture capital firms in regards to determining the efficacy, safety and investment value of medical technologies. Dr. Kopjar is active in a variety of research organizations including: AOSpine North America, The North American Spine Society (NASS), Cervical Spine Research Society (CSRS) and the International Scholarly Research Network (ISRN). He serves on the editorial board and as a reviewer for a number of academic journals and he is the current director of the Executive Master of Public Health program at the University of Washington. Dr. Kopjar holds the title of Distinguished Professor at Chongqing University in China. In the 2000's he held the title of Adviser to the Minister of Health for two European governments. He is a past recipient of the prestigious John M. Eisenberg Article-of-the-Year award.
Arnold PM, Sasso RC, Janssen ME, Fehlings MG, Heary RF, Vaccaro AR, Kopjar B. i-Factor Bone Graft vs Autograft in Anterior Cervical Discectomy and Fusion: 2-Year Follow-up of the Randomized Single-Blinded Food and Drug Administration Investigational Device Exemption Study. Neurosurgery. 2017 Sep 8. doi: 10.1093/neuros/nyx432. [Epub ahead of print] PMID: 28945914
Fehlings MG, Kopjar B, Ibrahim A, Tetreault LA, Arnold PM, Defino H, Kale SS, Yoon ST, Barbagallo GM, Bartels RHM, Zhou Q, Vaccaro AR, Zileli M, Tan G, Yukawa Y, Brodke DS, Shaffrey CI, Santos de Moraes O, Woodard EJ, Scerrati M, Tanaka M, Toyone T, Sasso RC, Janssen ME, Gokaslan ZL, Alvarado M, Bolger C, Bono CM, Dekutoski MB. Geographic variations in clinical presentation and outcomes of decompressive surgery in patients with symptomatic degenerative cervical myelopathy: analysis of a prospective, international multicenter cohort study of 757 patients. Spine J. 2017 Sep 6. pii: S1529-9430(17)30982-8. doi: 10.1016/j.spinee.2017.08.265. [Epub ahead of print] PMID: 28888674
Nagoshi N, Tetreault L, Nakashima H, Arnold PM, Barbagallo G, Kopjar B, Fehlings MG. Risk Factors for and Clinical Outcomes of Dysphagia After Anterior Cervical Surgery for Degenerative Cervical Myelopathy: Results from the AOSpine International and North America Studies. J Bone Joint Surg Am. 2017 Jul 5;99(13):1069-1077. doi: 10.2106/JBJS.16.00325. PMID: 28678119
Tetreault L, Nagoshi N, Nakashima H, Singh A, Kopjar B, Arnold P, Fehlings MG. Impact of Depression and Bipolar Disorders on Functional and Quality of Life Outcomes in Patients Undergoing Surgery for Degenerative Cervical Myelopathy: Analysis of a Combined Prospective Dataset. Spine (Phila Pa 1976). 2017 Mar 15;42(6):372-378. doi: 10.1097/BRS.0000000000001777. PMID: 27398891
PI: Kopjar Dates: 4/1/2011 - 12/31/2016
The aim of this study is to evaluate efficacy and safety of riluzole in the treatment of patients with acute spinal cord injury (SCI).
Efficacy of Riluzole in Surgical Treatment for Cervical Spondylotic Myelopathy (CSM-Protect)
Study of the efficacy of Riluzole in patients with cervical spondylotic myelopathy undergoing surgical treatment. A randomized, double-blind, placebo-controlled multi-center study